It wasn't so long ago when diabetes was
one of the hot sectors of med-tech where many companies felt they had
to have a presence, no matter what the cost. And while it is true
that the incidence of diabetes continues to increase at worrisome
rates in many countries, the diabetes market is no longer a “build
it (or buy it), and the growth will come” type of proposition. It
may not be quite true that diabetes as become a “winner takes all”
sort of market, it is definitely a market where data, pricing, and
marketing muscle make a big difference.
Please click below to continue:
http://www.massdevice.com/blogs/massdevice/strange-case-diabetes-market
No comments:
Post a Comment